OBIO
Price
$5.68
Change
+$0.06 (+1.07%)
Updated
Nov 6, 04:59 PM (EDT)
Capitalization
337.79M
3 days until earnings call
Intraday BUY SELL Signals
UNCY
Price
$3.54
Change
+$0.06 (+1.72%)
Updated
Nov 6, 03:27 PM (EDT)
Capitalization
96.94M
5 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OBIO vs UNCY

OBIO vs UNCY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
OBIO vs. UNCY commentary
Nov 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OBIO is a Hold and UNCY is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for OBIO with price predictions
Nov 05, 2026

OBIO saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for OBIO moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 56 similar instances where the indicator exited the overbought zone. In 45 of the 56 cases the stock moved lower. This puts the odds of a downward move at 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for OBIO turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 32 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.

OBIO moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OBIO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on OBIO as a result. In 70 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

The 10-day moving average for OBIO crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.

Following a +5.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where OBIO advanced for three days, in 164 of 215 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

OBIO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 133 of 181 cases where OBIO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. OBIO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.481) is normal, around the industry mean (2.788). P/E Ratio (-6.690) is within average values for comparable stocks, (-0.376). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.911) among similar stocks. P/S Ratio (11.198) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OBIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for UNCY with price predictions
Nov 05, 2026

UNCY in upward trend: price may jump up because it broke its lower Bollinger Band on October 02, 2026

UNCY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 35 of 39 cases where UNCY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where UNCY's RSI Oscillator exited the oversold zone, 28 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 62 of 73 cases where UNCY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

The Moving Average Convergence Divergence (MACD) for UNCY just turned positive on October 22, 2026. Looking at past instances where UNCY's MACD turned positive, the stock continued to rise in 40 of 48 cases over the following month. The odds of a continued upward trend are 83%.

Following a +7.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where UNCY advanced for three days, in 209 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UNCY as a result. In 89 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNCY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for UNCY entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.820) is normal, around the industry mean (2.788). P/E Ratio (-1.989) is within average values for comparable stocks, (-0.376). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.911) among similar stocks. P/S Ratio (39.216) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. UNCY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
OBIO: Fundamental Ratings
OBIO
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
22

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OBIOUNCY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Nov 06, 2026
Stock price -- (OBIO: $5.62 vs. UNCY: $3.48)
Brand notoriety: OBIO and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OBIO: 64% vs. UNCY: 149%
Market capitalization -- OBIO: $337.79M vs. UNCY: $96.94M
OBIO [@Biotechnology] is valued at $337.79M. UNCY’s [@Biotechnology] market capitalization is $96.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $137.5B. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OBIO’s FA Score shows that 0 FA rating(s) are green while UNCY’s FA Score has 1 green FA rating(s).

  • OBIO’s FA Score: 0 green, 5 red.
  • UNCY’s FA Score: 1 green, 4 red.
According to our system of comparison, UNCY is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OBIO’s TA Score shows that 5 TA indicator(s) are bullish while UNCY’s TA Score has 5 bullish TA indicator(s).

  • OBIO’s TA Score: 5 bullish, 4 bearish.
  • UNCY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, UNCY is a better buy in the short-term than OBIO.

Price Growth

OBIO (@Biotechnology) experienced а -7.72% price change this week, while UNCY (@Biotechnology) price change was -8.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was -15.16%.

Reported Earning Dates

OBIO is expected to report earnings on Nov 09, 2026.

UNCY is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

UNCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, UNCY has been loosely correlated with NVCT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if UNCY jumps, then NVCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
-7.20%
NVCT - UNCY
52%
Loosely correlated
-3.84%
ICU - UNCY
46%
Loosely correlated
-5.88%
VTGN - UNCY
43%
Loosely correlated
-10.36%
OBIO - UNCY
35%
Loosely correlated
-6.33%
LQDA - UNCY
34%
Loosely correlated
-6.10%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PLTZ10.591.75
+19.80%
Defiance Daily Target 2x Short PLTR ETF (PLTZ)
BSMR23.50-0.01
-0.02%
Invesco BulletShares 2027 Municipal Bond ETF (BSMR)
RQI11.74-0.27
-2.25%
COHEN & STEERS QUALITY Income REALTY FUND
TMFM22.53-0.65
-2.79%
Motley Fool Mid-Cap Growth ETF (TMFM)
TEXX27.28-0.87
-3.10%
Horizon Kinetics Texas ETF (TEXX)